Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 14, Pages 3146
Publisher
MDPI AG
Online
2020-07-10
DOI
10.3390/molecules25143146
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway
- (2020) Bing-Huei Chen et al. Scientific Reports
- Ginger: A novel strategy to battle cancer through modulating cell signalling pathways
- (2019) Ahmad Almatroudi et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
- (2019) Dongdong Wu et al. Cancer Cell International
- Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways.
- (2019) Saleh A. Almatroodi et al. Anti-Cancer Agents in Medicinal Chemistry
- Enoxacin and Epigallocatechin Gallate (EGCG) Act Synergistically to Inhibit the Growth of Cervical Cancer Cells in Culture
- (2019) Anna Margaret McDonnell et al. MOLECULES
- The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In�vitro and in�vivo murine xenograft study
- (2019) Hitoshi Yoshimura et al. Molecular Medicine Reports
- Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells
- (2019) Chueh-Hsuan Lu et al. PLoS One
- Emodin: Its role in prostate cancer‑associated inflammation (Review)
- (2019) Yanjie Tu et al. ONCOLOGY REPORTS
- Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial
- (2019) Wanqi Zhu et al. INVESTIGATIONAL NEW DRUGS
- Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial–Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine
- (2019) Wei et al. Nutrients
- Epigallocatechin-3-Gallate (EGCG), An Active Constituent of Green Tea: Implications in the Prevention of Liver Injury Induced by Diethylnitrosamine (DEN) in Rats
- (2019) Saleh A. Almatroodi et al. Applied Sciences-Basel
- Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
- (2019) Wei et al. Cancers
- Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review
- (2019) Wenzhong Dai et al. Journal of Functional Foods
- A prodrug of green tea polyphenol (–)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer
- (2018) Jianzhang Wang et al. CANCER LETTERS
- Nanoemulsion delivery system of tea polyphenols enhanced the bioavailability of catechins in rats
- (2018) Yunru Peng et al. FOOD CHEMISTRY
- SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
- (2018) Wanchun Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways
- (2018) Liang Cheng et al. Oxidative Medicine and Cellular Longevity
- Preparation of chitosan-Epigallocatechin-3-O-gallate nanoparticles and their inhibitory effect on the growth of breast cancer cells
- (2018) Yingyi Liu et al. Journal of Innovative Optical Health Sciences
- Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer
- (2018) Pan Jiang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line
- (2018) Debolina Pal et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Bioavailability of Tea Catechins and Its Improvement
- (2018) Zhuo-Yu Cai et al. MOLECULES
- Suppressive Effects of EGCG on Cervical Cancer
- (2018) Ying-Qi Wang et al. MOLECULES
- Achievable Central Nervous System Concentrations of the Green Tea Catechin EGCG Induce Stress in Glioblastoma Cells in Vitro
- (2018) Susanne Grube et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats
- (2018) Guojuan Zhang et al. Drug Design Development and Therapy
- Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway
- (2017) Chenxiao Yu et al. International Journal of Biological Sciences
- Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells
- (2017) Ching-Yi Tsai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy
- (2017) Shian-Ren Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN
- (2017) Shifei Yao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Polymeric nanoparticles: Promising platform for drug delivery
- (2017) Khalid M. El-Say et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9
- (2017) Ke-Wang Luo et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells
- (2017) Veronika Borutinskaitė et al. LEUKEMIA & LYMPHOMA
- Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
- (2017) Liang Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase
- (2017) Maliheh Moradzadeh et al. Pharmacological Reports
- Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RARα and HDAC1
- (2017) Maliheh Moradzadeh et al. PHYTOTHERAPY RESEARCH
- Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice
- (2017) Xin Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer
- (2017) Chao-You Huang et al. Oncology Letters
- Epigallocatechin‑3‑gallate induces apoptosis in acute promyelocytic leukemia cells via a SHP‑1‑p38α MAPK‑Bax cascade
- (2017) Liugen Gan et al. Oncology Letters
- Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer
- (2017) Hongsheng Tang et al. Oncotarget
- Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
- (2017) G Jin et al. Oncogenesis
- An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
- (2017) Munawar Mohammed et al. Pharmaceutics
- Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
- (2017) Vanna Sanna et al. Scientific Reports
- Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
- (2016) Hanxi Zhao et al. BRITISH JOURNAL OF RADIOLOGY
- Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling
- (2016) Chien-Han Yuan et al. ENVIRONMENTAL TOXICOLOGY
- Inhibition of green tea polyphenol EGCG((−)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway
- (2016) Chenggang Yang et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Fabrication of BSA–Green Tea Polyphenols–Chitosan Nanoparticles and Their Role in Radioprotection: A Molecular and Biochemical Approach
- (2016) Sumit Kumar et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways
- (2016) Subhayan Sur et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells
- (2016) Xiaohua Pan et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- (−)-Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN
- (2016) SHI LIU et al. Molecular Medicine Reports
- EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation
- (2016) MIN LI et al. ONCOLOGY REPORTS
- Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
- (2016) Yoo Seob Shin et al. PHYTOMEDICINE
- Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
- (2016) Tae Won Kwak et al. OncoTargets and Therapy
- Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
- (2016) SHAO-JUN CHEN et al. Experimental and Therapeutic Medicine
- Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins
- (2016) Nagi B. Kumar et al. Oncotarget
- In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity
- (2016) Sainan Li et al. Scientific Reports
- Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2
- (2015) Abedul Haque et al. APOPTOSIS
- Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells
- (2015) Dae-Woon Eom et al. BMB Reports
- The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
- (2015) Christian Mayr et al. BMC Complementary and Alternative Medicine
- Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention
- (2015) N. B. Kumar et al. Cancer Prevention Research
- (−)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation
- (2015) JIANGYAN WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells
- (2015) Fen Hu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- (−)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells
- (2015) MUNAWWAR ALI KHAN et al. ONCOLOGY REPORTS
- Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1
- (2015) Kewei Zhu et al. TUMOR BIOLOGY
- Inhibitory effect of (−)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth
- (2015) Sabrina Bimonte et al. Infectious Agents and Cancer
- Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate
- (2015) Liangdong Jiang et al. World Journal of Surgical Oncology
- Green Tea Polyphenol Epigallocatechin-3-Gallate Inhibits TNF-a-Induced Production of Monocyte Chemoattractant Protein-1 in Human Umbilical Vein Endothelial Cells
- (2014) Ze-Mu Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways
- (2014) Arshad H. Rahmani et al. Evidence-based Complementary and Alternative Medicine
- Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate
- (2014) Sabita N. Saldanha et al. EXPERIMENTAL CELL RESEARCH
- Improved in vitro digestion stability of (−)-epigallocatechin gallate through nanoliposome encapsulation
- (2014) Li-qiang Zou et al. FOOD RESEARCH INTERNATIONAL
- Epigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cells
- (2014) YUNJUAN ZHANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway
- (2014) Mohamed M. Darweish et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Reversal of Cisplatin Resistance by Epigallocatechin Gallate Is Mediated by Downregulation of Axl and Tyro 3 Expression in Human Lung Cancer Cells
- (2014) Kyung-Chan Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Metabolic consequences of LDHA inhibition by epigallocatechin gallate and oxamate in MIA PaCa-2 pancreatic cancer cells
- (2014) Qing-Yi Lu et al. Metabolomics
- Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo
- (2014) LIFENG LIU et al. ONCOLOGY REPORTS
- Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin
- (2014) Jianping Chen et al. PLoS One
- A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer
- (2014) Hanxi Zhao et al. RADIOTHERAPY AND ONCOLOGY
- Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors
- (2014) Mark E. Stearns et al. Translational Oncology
- Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways
- (2014) Arshad H. Rahmani et al. Biomed Research International
- PI3K/AKT/mTOR Signaling is Involved in (-)-Epigallocatechin-3-Gallate-Induced Apoptosis of Human Pancreatic Carcinoma Cells
- (2013) Shi Liu et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
- (2013) Ying Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model
- (2013) N. Khan et al. CARCINOGENESIS
- Induction of the Connexin 32 Gene by Epigallocatechin-3-Gallate Potentiates Vinblastine-Induced Cytotoxicity in Human Renal Carcinoma Cells
- (2013) Ayami Sato et al. CHEMOTHERAPY
- Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway
- (2013) Sang Hyuk Lee et al. EUROPEAN JOURNAL OF CANCER
- Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells
- (2013) Tae Won Kwak et al. Evidence-based Complementary and Alternative Medicine
- Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation
- (2013) Huaping Chen et al. EXPERIMENTAL CELL RESEARCH
- Lipase-catalyzed synthesis of acetylated EGCG and antioxidant properties of the acetylated derivatives
- (2013) Song Zhu et al. FOOD RESEARCH INTERNATIONAL
- A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer
- (2013) Dominique Trudel et al. GYNECOLOGIC ONCOLOGY
- Regulation of Id1 expression by epigallocatechin-3-gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells
- (2013) JUN MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model
- (2013) JERZY JANKUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Nanoencapsulation Enhances Epigallocatechin-3-gallate Stability and Its Antiatherogenic Bioactivities in Macrophages
- (2013) Jia Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines
- (2013) Francesca De Amicis et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells
- (2013) S. Haratifar et al. JOURNAL OF DAIRY SCIENCE
- Mechanism of the inhibition of the STAT3 signaling pathway by EGCG
- (2013) YANG WANG et al. ONCOLOGY REPORTS
- Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway
- (2013) YU-CHAO MA et al. ONCOLOGY REPORTS
- Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells
- (2013) LONGYU JIN et al. ONCOLOGY REPORTS
- Quercetin and EGCG Exhibit Chemopreventive Effects in Cholangiocarcinoma Cells via Suppression of JAK/STAT Signaling Pathway
- (2013) Laddawan Senggunprai et al. PHYTOTHERAPY RESEARCH
- Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell
- (2013) Hong Li et al. Neuroscience Bulletin
- (−)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357
- (2012) Carmen Härdtner et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation
- (2012) SEUNG BIN PARK et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity
- (2012) Ho-Geun Yoon INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells
- (2012) ANNE-SOPHIE HÖNICKE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- (−)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation
- (2012) Murli Manohar et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Protective effects of (−)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition
- (2012) I-Ta Lee et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin
- (2012) Fei Ye WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression
- (2011) Chunxiao Yan et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion
- (2011) Lixia Z. Ellis et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles
- (2011) Dar-Shih Hsieh et al. BIOMATERIALS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma
- (2011) Minakshi Nihal et al. CELL CYCLE
- Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
- (2011) Michael Frezza et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression
- (2011) Watanabe INTERNATIONAL JOURNAL OF ONCOLOGY
- Epigallocatechin-3 Gallate Inhibits Invasion, Epithelial−Mesenchymal Transition, and Tumor Growth in Oral Cancer Cells
- (2011) Pei-Ni Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells
- (2011) Oana Tudoran et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Green tea (−)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met
- (2011) Yoon Woo Koh et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: Roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways
- (2011) Yung-Chang Lin ONCOLOGY REPORTS
- The chemistry and biotransformation of tea constituents
- (2011) Shengmin Sang et al. PHARMACOLOGICAL RESEARCH
- Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling Studies
- (2010) Mark E. Stearns et al. AMERICAN JOURNAL OF PATHOLOGY
- Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate
- (2010) Admire Dube et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Green tea: A promising anticancer agent for renal cell carcinoma
- (2010) Márcia Carvalho et al. FOOD CHEMISTRY
- Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution
- (2010) Admire Dube et al. FOOD CHEMISTRY
- Antihypertensive Effect of Benifuuki Tea ContainingO-Methylated EGCG
- (2010) Ikuko Kurita et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate
- (2010) Yan Wu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Anti-Melanoma Effects of Vorinostat in Combination with Polyphenolic Antioxidant (−)-Epigallocatechin-3-Gallate (EGCG)
- (2010) Minakshi Nihal et al. PHARMACEUTICAL RESEARCH
- Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells
- (2009) Q. Wang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Green Tea Catechin Controls Apoptosis in Colon Cancer Cells by Attenuation of H2O2-Stimulated COX-2 Expression via the AMPK Signaling Pathway at Low-Dose H2O2
- (2009) In-Ja Park et al. Annals of the New York Academy of Sciences
- Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells
- (2009) Dong Hoon Han et al. ARCHIVES OF PHARMACAL RESEARCH
- Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor- B
- (2009) A. R. M. R. Amin et al. Cancer Prevention Research
- (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells
- (2009) S. Adachi et al. CARCINOGENESIS
- Indoleamine 2,3-Dioxygenase, an Immunomodulatory Protein, Is Suppressed by (−)-Epigallocatechin-3-gallate via Blocking of γ-Interferon-Induced JAK-PKC-δ-STAT1 Signaling in Human Oral Cancer Cells
- (2009) Chieh-Wen Cheng et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells
- (2009) Molly Lang et al. LIVER INTERNATIONAL
- A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
- (2008) M J Scandlyn et al. BRITISH JOURNAL OF CANCER
- Oxidative stress, DNA methylation and carcinogenesis
- (2008) Rodrigo Franco et al. CANCER LETTERS
- Green tea extract, epigallocatechin-3-gallate, inhibits the growth and invasive ability of human glioma cells
- (2008) Zhang Molecular Medicine Reports
- Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma
- (2008) M.D. Siegelin et al. NEUROSCIENCE LETTERS
- Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation
- (2007) Daniel S. Albrecht et al. CHEMICO-BIOLOGICAL INTERACTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started